SCHEMBL979329

SCHEMBL979329

O=C(Cc1ccc2nsnc2c1)N1CCC(c2cc(F)cc(F)c2)=N1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.37
RAB9A P51151 3/20 0.37
HPGD P15428 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
ECE2 P0DPD6 1/20 0.36
HCRTR1 O43613 1/20 0.34
MAPT P10636 3/20 0.33
MAOB P27338 2/20 0.33
NPC1 O15118 1/20 0.33
KDM4E B2RXH2 4/20 0.33
THRB P10828 2/20 0.33
OPRK1 P41145 1/20 0.33
EDNRB P24530 3/20 0.32
EDNRA P25101 2/20 0.32
CASP3 P42574 1/20 0.32
SENP8 Q96LD8 1/20 0.32
SENP7 Q9BQF6 1/20 0.32
SENP6 Q9GZR1 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
PPARG P37231 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL979417 0.91 MAOB (0.43) ALDH1A1RAB9AHPGDSMN1; SMN2ECE2
SCHEMBL17004388 0.91 GRM5 (0.39) ALDH1A1RAB9AHPGDSMN1; SMN2ECE2
SCHEMBL984420 0.87 HCRTR1 (0.45) ALDH1A1RAB9AHPGDSMN1; SMN2ECE2
SCHEMBL980719 0.86 ALDH1A1 (0.42) ALDH1A1RAB9AHPGDSMN1; SMN2ECE2
SCHEMBL980254 0.85 PGR (0.46) ALDH1A1RAB9AHPGDSMN1; SMN2ECE2
SCHEMBL981273 0.85 PGR (0.42) ALDH1A1RAB9AHPGDSMN1; SMN2ECE2
SCHEMBL979452 0.82 PGR (0.41) ALDH1A1RAB9AHPGDSMN1; SMN2HCRTR1
SCHEMBL984590 0.81 MAOB (0.41) ALDH1A1RAB9AHPGDSMN1; SMN2HCRTR1
SCHEMBL980474 0.81 MAOB (0.58) ALDH1A1RAB9AHPGDSMN1; SMN2MAOB
SCHEMBL980139 0.80 SMN1; SMN2 (0.35) ALDH1A1RAB9AHPGDSMN1; SMN2ECE2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1917248-B1 1-ACYLDIHYDROPYRAZOL DERIVATIVES MERCK PATENT GMBH (DE) 2015-08-19 EP claimed
US-7875644-B2 tyrosine kinase inhibitors, in particular Met kinase; antitumor agents;1-(Benzo-1,2,5-thiadiazol-5-ylmethylcarbonyl)-3-(2,4-dimethoxyphenyl)-4,5-dihydro-1H-pyrazole; leukemia, carcinomas MERCK PATENT GMBH (DE) 2011-01-25 US claimed
US-20080249095-A1 1-Acyldihydropyrazole Derivatives MERCK PATENT GESELLSCHAFT (DE) 2008-10-09 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080249095-A1 1-Acyldihydropyrazole Derivatives MET, FLT3, ERBB3 ALDH1A1 399/4885RAB9A 2347/4885HPGD 2204/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.